Cargando…
Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
Lack of disease-modifying therapy against epileptogenesis reflects the complexity of the disease pathogenesis as well as the high demand to explore novel treatment strategies. In the pursuit of developing new therapeutic strategies against epileptogenesis, neurodegenerative proteins have recently ga...
Autores principales: | Paudel, Yam Nath, Angelopoulou, Efthalia, Piperi, Christina, Othman, Iekhsan, Shaikh, Mohd. Farooq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344698/ https://www.ncbi.nlm.nih.gov/pubmed/32545604 http://dx.doi.org/10.3390/biology9060122 |
Ejemplares similares
-
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
por: Paudel, Yam Nath, et al.
Publicado: (2020) -
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
por: Paudel, Yam Nath, et al.
Publicado: (2020) -
From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
por: Paudel, Yam Nath, et al.
Publicado: (2020) -
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020) -
Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)